Targeting therapy with central venous access devices

Nursing

Volumn 38, Issue 6, 2008, Pages 34-40

  Hadaway, Lynn C ^a  

^a Lynn Hadaway Associates Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BANDAGE; CENTRAL VENOUS CATHETERIZATION; EQUIPMENT; EQUIPMENT DESIGN; HUMAN; INFECTION CONTROL; INSTRUMENTATION; LAVAGE; METHODOLOGY; NURSE ATTITUDE; NURSING; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SKIN CARE;

BANDAGES; CATHETERIZATION, CENTRAL VENOUS; EQUIPMENT DESIGN; EQUIPMENT FAILURE; HUMANS; INFECTION CONTROL; IRRIGATION; NURSE'S ROLE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SKIN CARE;

EID: 52049120342     PISSN: 03604039     EISSN: 15388689     Source Type: Journal    
DOI: 10.1097/01.NURSE.0000320355.17197.56     Document Type: Article

References (21)

1. Infusion Nurses Society. Infusion Nursing Standards of Practice. Journal of InfusionNursing. 29(1 Suppl.):S1-S92, January-February 2006.
2. Food and Drug Administration. National Technical Information Services. Central venous catheter complications video. http://www.fda.gov/cdrh/ohip/dupsa/cvcvideo.html
3. Shannon R.P., et al. Eliminating central line-associated bloodstream infections in the CCU/MICU. Institute for Healthcare Improvement. http://www.ihi.org/IHI/Topics/CriticalCare/IntensiveCare/ImprovementStories/EliminatingCentralLineAssociatedBloodstreamInfectionsintheCCUMICU.htm
4. O’Grady N.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Morbidity and Mortality Weekly Report. 51(RR1-0):1-29, August 9, 2002.
5. Boyce J., Pittet D. Centers for Disease Control and Prevention: Guideline for hand hygiene in health-care settings. Morbidity and Mortality Weekly Report. 51(RR-16):1-44, October 25, 2002.
6. Chaiyakunapruk N., et al. Chlorhexidine compared with povidone-iodine solutions for vascular catheter-site care: A meta-analysis. Annals of Internal Medicine. 136(11):792-801, June 4, 2002.
7. Levy I., et al. Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: A randomized controlled study. Pediatric Infectious Disease Journal. 24(8):676-679, August 2005.
8. Banton J., Banning V. Impact on catheter-related bloodstream infections with the use of the Biopatch dressing. Journal of the Association for Vascular Access. 7(3):27-32, Fall 2002.
9. Garland J.S., et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics. 107(6):1431-1436, June 2001.
10. Crawford A., et al. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections. Infection Control and Hospital Epidemiology. 25(8):668-674, August 2004.
11. Hadaway L. Hub disinfection and its impact on catheter-related infections. Journal of Vascular Access Devices. 6(2):33-36, Summer 2001.
12. Donlan R., et al. Protocol for detection of biofilms on needleless connectors attached to central venous catheters. Journal of Clinical Microbiology. 39(2):750-753, February 2001.
13. Rupp M., et al. Outbreak of bloodstream infection temporally associated with the use of an intravascular needleless valve. Clinical Infectious Diseases. 44(11):1408-1414, June 1, 2007.
14. Salgado C., et al. Increased rate of catheter-related bloodstream infection associated with use of a needleless mechanical valve device at a long-term acute care hospital. Infection Control and Hospital Epidemiology. 28(6):684-688, June 2007.
15. Field K., et al. Incidence of catheter-related bloodstream infection among patients with a needleless, mechanical valve-based intravenous connector in an Australian hematology-oncology unit. Infection Control and Hospital Epidemiology. 28(5):610-613, May 2007.
16. Schears G. Summary of product trials for 10,164 patients: Comparing an intravenous stabilizing device to tape. Journal of Infusion Nursing. 29(4):225-231, July-August 2006.
17. Yamamoto A. et al. Sutureless securement device reduces complications of peripherally inserted central venous catheters. Journal of Vascular and Interventional Radiology. 13(1):77-81, January 2002.
18. Hadaway L.C. Reopen the pipeline for I.V. therapy. Nursing2005. 35(8):54-63, August 2005.
19. Hadaway L. Technology of flushing vascular access devices. Journal of Infusion Nursing. 29(3):129-145, May-June 2006.
20. Hadaway L. Flushing vascular access catheters: Risks for infection transmission. Infection Control Resource. 4(2):1-8, 2007.
21. Maragakis L., et al. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infection Control and Hospital Epidemiology. 27(12):67-70, January 2006.